Lu SY - Search Results

1

Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma.

Lu SY, Sui YF, Li ZS, Pan CE, Ye J, Wang WY. Lu SY, et al. World J Gastroenterol. 2003 Apr;9(4):688-91. doi: 10.3748/wjg.v9.i4.688. World J Gastroenterol. 2003. PMID: 12679911 Free PMC article.

2

[Establishment of a human cervical carcinoma cell line HCC-0214 and its biological characteristics].

Dong HL, Sui YF, Qu P, Li ZS, Lu SY, Zhang SZ, Ye J, Chen GS. Dong HL, et al. Among authors: lu sy. Zhonghua Zhong Liu Za Zhi. 2003 Jan;25(1):43-6. Zhonghua Zhong Liu Za Zhi. 2003. PMID: 12678986 Chinese.

3

[Prediction synthesis and identification of HLA-A2-restricted cytotoxic T lymphocyte epitopes of the tumor antigen MAGE-n].

Dong HL, Sui YF, Ye J, Li ZS, Qu P, Zhang XM, Chen GS, Lu SY. Dong HL, et al. Among authors: lu sy. Zhonghua Yi Xue Za Zhi. 2003 Jun 25;83(12):1080-3. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12899783 Chinese.

4

Superantigen-SEA gene modified tumor vaccine for hepatocellular carcinoma: an in vitro study.

Lu SY, Sui YF, Li ZS, Ye J, Dong HL, Qu P, Zhang XM, Wang WY, Li YS. Lu SY, et al. World J Gastroenterol. 2004 Jan;10(1):53-7. doi: 10.3748/wjg.v10.i1.53. World J Gastroenterol. 2004. PMID: 14695768 Free PMC article.

5

In vivo tumor co-transfection with superantigen and CD80 induces systemic immunity without tolerance and prolongs survival in mice with hepatocellular carcinoma.

Li ZS, Yang XW, Chen Z, Dong HL, Ye J, Qu P, Lu SY, Zhang XM, Sui YF. Li ZS, et al. Among authors: lu sy. Cancer Biol Ther. 2004 Jul;3(7):660-6. doi: 10.4161/cbt.3.7.920. Epub 2004 Jul 9. Cancer Biol Ther. 2004. PMID: 15136758 Free article.

6

[Construction of VEGF eukaryotic expression vector and its expression in endothelial cells and cardiac myocytes in-vitro].

Yu M, Qian YQ, Lu SY, Chen GS, Ye J. Yu M, et al. Among authors: lu sy. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003 May;19(3):223-4. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003. PMID: 15155076 Chinese.

7

[The construction and expression of a hepatocellular carcinoma-specific superantigen SEA (D227A) expression vector].

Lu SY, Sui YF, Li ZS, Pan CE, Ye J, Zhang XM, Wang WY. Lu SY, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003 Jul;19(4):353-6. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003. PMID: 15163383 Chinese.

8

[Study on immunoreaction induced by DCs loaded with hepatocarcinoma antigen peptide in-vitro].

Qu P, Sui YF, Guo AL, Cao YX, Dong HL, Lu SY, Ye J, Zhang XM. Qu P, et al. Among authors: lu sy. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003 Jul;19(4):406-8. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003. PMID: 15163400 Chinese.

9

Efficient induction of cytotoxic T lymphocytes specific to hepatocellular carcinoma using HLA-A2-restricted MAGE-n peptide in vitro.

Dong HL, Sui YF, Li ZS, Qu P, Wu W, Ye J, Zhang XM, Lu SY. Dong HL, et al. Among authors: lu sy. Cancer Lett. 2004 Aug 10;211(2):219-25. doi: 10.1016/j.canlet.2004.02.013. Cancer Lett. 2004. PMID: 15219945

10

Identification of HLA-A2-restricted CTL epitope encoded by the MAGE-n gene of human hepatocellular carcinoma.

Dong HL, Li ZS, Ye J, Qu P, Huang YY, Wu W, Lu SY, Chen GS, Sui YF. Dong HL, et al. Among authors: lu sy. Cancer Biol Ther. 2004 Sep;3(9):891-8. doi: 10.4161/cbt.3.9.1081. Epub 2004 Sep 15. Cancer Biol Ther. 2004. PMID: 15326372 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

749 results

Search Page

Filters